- Home
- KNSA vs BBUC Comparison
KNSA vs BBUC Comparison
Compare KNSA & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- BBUC
- Stock Information
- Founded
- KNSA 2015
- BBUC 2022
- Country
- KNSA United Kingdom
- BBUC United States
- Employees
- KNSA N/A
- BBUC N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- BBUC
- Sector
- KNSA Health Care
- BBUC
- Exchange
- KNSA Nasdaq
- BBUC Nasdaq
- Market Cap
- KNSA 2.6B
- BBUC 2.4B
- IPO Year
- KNSA 2018
- BBUC N/A
- Fundamental
- Price
- KNSA $38.01
- BBUC $36.30
- Analyst Decision
- KNSA Strong Buy
- BBUC
- Analyst Count
- KNSA 7
- BBUC 0
- Target Price
- KNSA $46.86
- BBUC N/A
- AVG Volume (30 Days)
- KNSA 454.2K
- BBUC 195.4K
- Earning Date
- KNSA 10-28-2025
- BBUC 11-06-2025
- Dividend Yield
- KNSA N/A
- BBUC 0.69%
- EPS Growth
- KNSA N/A
- BBUC N/A
- EPS
- KNSA 0.47
- BBUC N/A
- Revenue
- KNSA $597,973,000.00
- BBUC $8,240,000,000.00
- Revenue This Year
- KNSA $53.93
- BBUC N/A
- Revenue Next Year
- KNSA $25.06
- BBUC N/A
- P/E Ratio
- KNSA $84.46
- BBUC N/A
- Revenue Growth
- KNSA 55.68
- BBUC 6.96
- 52 Week Low
- KNSA $17.82
- BBUC $21.52
- 52 Week High
- KNSA $42.05
- BBUC $37.89
- Technical
- Relative Strength Index (RSI)
- KNSA 50.20
- BBUC 55.97
- Support Level
- KNSA $35.53
- BBUC $34.51
- Resistance Level
- KNSA $41.28
- BBUC $37.07
- Average True Range (ATR)
- KNSA 1.50
- BBUC 1.37
- MACD
- KNSA -0.14
- BBUC 0.02
- Stochastic Oscillator
- KNSA 43.13
- BBUC 65.36
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.